Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5R21HL145415-02, 5R21HL145415-02, 5R21HL145415-02, 5R21HL145415-02)
Translating Duke Health Children's Health & Discovery Initiative
Received: 18 December 2021
Accepted: 13 April 2022
First Online: 22 April 2022
: Duke University Health System Internal Review Board and granted a waiver of Informed consent for a retrospective analysis of existing patient data. All experimental protocols were performed in accordance with relevant guidelines and regulations and approved by the Duke University Health System Internal Review Board.
: Not applicable.
: JEL received consulting fees serving on the Regeneron Pediatric Asthma Field Advisory Board. JHH, CZ, HPH, MGG, and BAG do not have any competing interests to declare.